Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  DaVita    DVA

DAVITA (DVA)
Mes dernières consult.
Most popular
  Report  
Delayed Quote. Delayed  - 02/22 10:02:01 pm
72.07 USD   -0.66%
02/20DAVITA : Recognized Among 2018 Training Top 125 for Exceptional Trai..
PR
02/14DAVITA : cuts 38 jobs in Minneapolis
AQ
02/14DAVITA : Around nm
AQ
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
02/15/2018 02/16/2018 02/20/2018 02/21/2018 02/22/2018 Date
73.84(c) 73.65(c) 72.77(c) 72.55(c) 72.07(c) Last
1 841 981 1 302 583 1 364 135 1 085 030 1 311 657 Volume
-1.22% -0.26% -1.19% -0.30% -0.66% Change
More quotes
Financials ($)
Sales 2018 11 413 M
EBIT 2018 1 553 M
Net income 2018 653 M
Debt 2018 5 731 M
Yield 2018 -
Sales 2019 11 997 M
EBIT 2019 1 651 M
Net income 2019 777 M
Debt 2019 7 500 M
Yield 2019 -
P/E ratio 2018 17,87
P/E ratio 2019 13,33
EV / Sales2018 1,67x
EV / Sales2019 1,73x
Capitalization 13 298 M
More Financials
Company
DaVita, Inc. engages in the provision of medical care services.It operates through the following business segments: Kidney Care and HealthCare Partners.The Kidney Care segment focuses on the delivery of dialysis services to patients with chronic kidney failure and end stage renal disease.The... 
More about the company
Surperformance© ratings of DaVita
Trading Rating : Investor Rating :
More Ratings
Latest news on DAVITA
02/20DAVITA : Recognized Among 2018 Training Top 125 for Exceptional Training and Dev..
PR
02/14DAVITA : cuts 38 jobs in Minneapolis
AQ
02/14DAVITA : Around nm
AQ
02/14DAVITA : Kidney Care Encourages Americans to Become Organ Donors
PR
02/07DAVITA INC. : Change in Directors or Principal Officers (form 8-K)
AQ
02/05DAVITA : Government Report Reveals Dialysis Industry Improves Patient Care
PR
02/01DAVITA : Kidney Care Promotes Heart-Healthy Lifestyles During American Heart Mon..
PU
01/31DAVITA INC. : Schedules 4th Quarter 2017 Investor Conference Call
PR
01/31THE EVERETT CLINIC : Announces Senior Leadership Transitions
PR
01/23DAVITA : Recognized as a Top Green Company by Newsweek
PR
More news
Sector news : Healthcare Facilities & Services - NEC
02/20FRESENIUS : Helios Expands Two Hospitals in Germany
DJ
01/30HCA HOSPITAL AMERICA : Healtre 4Q Profit Hit by Higher Taxes; Plans Quarterly Di..
DJ
01/22UK stocks decline as gamblers stumble on government clampdown worries
RE
01/07Fresenius CFO backs acquisition course - Boersen-Zeitung
RE
2017FRESENIUS : FMC Expect Positive Impact From U.S. Tax Reform
DJ
More sector news : Healthcare Facilities & Services - NEC
4-Traders Strategies on DAVITA 
DAVITA HEALTHCARE PARTNERS - 2015
Anticipation of a bearish reversal
SELL
More Strategies
Latest Tweets
02/22Global X Management Co. LLC Sells 4,300 Shares of Davita Inc $DVA  
02/22$DVA - Bank of New York Mellon Corp Sells 83,911 Shares of Davita Inc #DVA  
02/21Davita Inc $DVA Stake Lowered by Comerica Bank  
02/20Research Report Identifies BofI Holding, TrueBlue, Essendant, DaVita HealthCa.. 
02/20DaVita Recognized Among 2018 Training Top 125 for Exceptional Training and De.. 
More tweets
Qtime:102
News from SeekingAlpha
02/18SA INTERVIEW : Special Situation Value Investing With Angry Uptick 
02/15Tracking Warren Buffett's Berkshire Hathaway Portfolio - Q4 2017 Update 
02/14DaVita HealthCare Partners' (DVA) CEO Kent Thiry on Q4 2017 Results - Earning.. 
02/13DaVita HealthCare Partners EPS of $0.92 
02/12Notable earnings after Tuesday?s close 
Chart DAVITA
Duration : Period :
DaVita Technical Analysis Chart | DVA | US23918K1088 | 4-Traders
Technical analysis trends DAVITA
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 11
Average target price 82,5 $
Spread / Average Target 14%
EPS Revisions
Managers
NameTitle
Kent J. Thiry Chairman & Chief Executive Officer
Joel Ackerman Chief Financial Officer
George R. Aronoff Chief Medical Officer
Peter Thacher Grauer Lead Independent Director
John M. Nehra Independent Director
Sector and Competitors